Understanding quality-adjusted life years and their application to pharmacoeconomic research (Q33992542)

30 July 2017

1 reference

title

Understanding quality-adjusted life years and their application to pharmacoeconomic research (English)

1 reference

30 July 2017

D W Raisch

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

Annals of Pharmacotherapy

30 July 2017

published in

1 reference

30 July 2017

volume

34

1 reference

30 July 2017

issue

7-8

1 reference

30 July 2017

page(s)

906-914

1 reference

The MOS 36-ltem Short-Form Health Survey (SF-36)

30 July 2017

cites work

1 reference

The cost-effectiveness of preventing AIDS-related opportunistic infections

21 January 2018

1 reference

Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people

21 January 2018

1 reference

Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research

21 January 2018

1 reference

Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine

21 January 2018

1 reference

Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues

21 January 2018

1 reference

Cost-effectiveness ratios: in a league of their own.

21 January 2018

1 reference

The use of QALY and non-QALY measures of health-related quality of life. Assessing the state of the art.

21 January 2018

1 reference

Common errors and controversies in pharmacoeconomic analyses

21 January 2018

1 reference

Heterogeneity in the relationship between the time tradeoff and Short Form-36 for HIV-infected and primary care patients.

21 January 2018

1 reference

Predicting Quality of Well-being scores from the SF-36: results from the Beaver Dam Health Outcomes Study

21 January 2018

1 reference

Multi-attribute preference functions. Health Utilities Index

21 January 2018

1 reference

Cost utility analysis: what should be measured?

21 January 2018

1 reference

Assessing the performance of utility techniques in the absence of a gold standard.

21 January 2018

1 reference

Associations between health status and utilities implications for policy

21 January 2018

1 reference

Evaluation of index and profile measures of health status in a randomized controlled trial. Comparison of the Medical Outcomes Study 36-Item Short Form Health Survey, EuroQol, and disease specific measures

21 January 2018

1 reference

Reliability of the Health Utilities Index--Mark III used in the 1991 cycle 6 Canadian General Social Survey Health Questionnaire.

21 January 2018

1 reference

Linking the health utilities index to National Medical Expenditure Survey data

21 January 2018

1 reference

Comparison of the health-related quality of life of extremely low birth weight children and a reference group of children at age eight years

21 January 2018

1 reference

Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey.

21 January 2018

1 reference

Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire.

21 January 2018

1 reference

Test-retest reliability of health state valuations collected with the EuroQol questionnaire.

21 January 2018

1 reference

Health state valuations from the general public using the visual analogue scale.

21 January 2018

1 reference

Cost-effectiveness league tables: More harm than good?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.19314

1 reference

30 July 2017

1 reference